| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41598-017-06328-3 |
| P8608 | Fatcat ID | release_bvb4fo5tcbgqhdsfcb53ouei6m |
| P932 | PMC publication ID | 5522426 |
| P698 | PubMed publication ID | 28733598 |
| P50 | author | John Zhong Li | Q57338468 |
| P2093 | author name string | Min Guo | |
| Qian Wang | |||
| Ning Wang | |||
| Jing Jiang | |||
| Jizheng Chen | |||
| Xinwen Chen | |||
| Yu Pan | |||
| Junqi Niu | |||
| Xiumei Chi | |||
| Zhilei Zhang | |||
| Sulaiman Ksimu | |||
| P2860 | cites work | Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase-Dependent Regulation of the Orphan Nuclear Receptor SHP | Q22241295 |
| Isolation and characterization of a novel member of the gene family encoding the cAMP response element-binding protein CRE-BP1 | Q24321748 | ||
| Epigenetics: a molecular link between environmental factors and type 2 diabetes | Q24652830 | ||
| The interaction of hepatic lipid and glucose metabolism in liver diseases | Q26827770 | ||
| New and emerging HDAC inhibitors for cancer treatment | Q27022413 | ||
| Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 | Q28216275 | ||
| The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism | Q28594811 | ||
| Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway | Q28728915 | ||
| CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 | Q29615692 | ||
| Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway | Q30395512 | ||
| Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism | Q33965224 | ||
| Endoplasmic reticulum stress links hepatitis C virus RNA replication to wild-type PGC-1α/liver-specific PGC-1α upregulation | Q34057855 | ||
| CREB and the CRTC co-activators: sensors for hormonal and metabolic signals | Q34166530 | ||
| Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha ) and mitochondrial function by MEF2 and HDAC5 | Q34761571 | ||
| The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment | Q35075630 | ||
| Phosphatidylserine-specific phospholipase A1 involved in hepatitis C virus assembly through NS2 complex formation | Q35115608 | ||
| Characterization of novel peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) isoform in human liver. | Q35604515 | ||
| Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study | Q35606593 | ||
| Inhibition of FOXO1 by small interfering RNA enhances proliferation and inhibits apoptosis of papillary thyroid carcinoma cells via Akt/FOXO1/Bim pathway | Q36352337 | ||
| Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis. | Q36462551 | ||
| Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner | Q36994027 | ||
| The Metabolic Regulator Histone Deacetylase 9 Contributes to Glucose Homeostasis Abnormality Induced by Hepatitis C Virus Infection | Q38831352 | ||
| The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance. | Q39325440 | ||
| Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus | Q39835772 | ||
| Nuclear receptors control pro-viral and antiviral metabolic responses to hepatitis C virus infection. | Q40490998 | ||
| Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. | Q40667994 | ||
| Distinction between AP1 and NF-E2 factor-binding at specific chromatin regions in mammalian cells | Q41692278 | ||
| Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C. | Q42456523 | ||
| Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis | Q42681991 | ||
| FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression | Q46955933 | ||
| Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner. | Q47855534 | ||
| Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition. | Q51359140 | ||
| GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice. | Q54383388 | ||
| PGC-1α encoded by the PPARGC1A gene regulates oxidative energy metabolism in equine skeletal muscle during exercise. | Q54524509 | ||
| Mechanisms by which fatty-acyl-CoA esters inhibit or activate glucose-6-phosphatase in intact and detergent-treated rat liver microsomes | Q71130148 | ||
| Metabolic disease: New role for HDACs in glucose homeostasis | Q84483229 | ||
| Light activation of fructose bisphosphatase in isolated spinach chloroplasts and deactivation by hydrogen peroxide : A physiological role for the thioredoxin system | Q86885670 | ||
| P2507 | corrigendum / erratum | Author Correction: Role of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis | Q95933783 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gluconeogenesis | Q191835 |
| hepatic gluconeogenesis | Q106966449 | ||
| P304 | page(s) | 6102 | |
| P577 | publication date | 2017-07-21 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Role of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis | |
| P478 | volume | 7 |
| Q94454420 | Histone Deacetylase 9: Its Role in the Pathogenesis of Diabetes and Other Chronic Diseases |
| Q91013912 | Metabolic rearrangements in primary liver cancers: cause and consequences |
| Q92874876 | Phosphorylation of Forkhead Protein FoxO1 at S253 Regulates Glucose Homeostasis in Mice |
| Q89529397 | Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer |
Search more.